Literature DB >> 1572135

The hemolysin/bacteriocin produced by enterococci is a marker of pathogenicity.

C R Libertin1, R Dumitru, D S Stein.   

Abstract

The hemolysin/bacteriocin produced by some strains of Enterococcus faecalis is active in the lysis of human, rabbit, and horse erythrocytes, but not those from sheep. In this study, we determined that 20% of clinical enterococcal isolates tested in the clinical microbiology laboratory produced hemolysin and that pathogenic human E. faecalis were more likely to be hemolysin-producing isolates. Among the organisms isolated from different anatomic sites, variability in the degree of hemolysin production existed. We used an isogenic pair of E. faecalis organisms to demonstrate that hemolysin production was due to a hemolysin/bacteriocin determinant transmissible by a plasmid and was not strain dependent. This determinant may be linked to antibiotic resistance genes in some instances. Also, the erythrocyte lysis occurred only when hemolysin was in the presence of E. faecalis organisms, suggesting a bacterial cell dependency for activity of the hemolysin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1572135     DOI: 10.1016/0732-8893(92)90033-p

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  10 in total

Review 1.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Mechanisms of Hemolysis During Sepsis.

Authors:  Katharina Effenberger-Neidnicht; Matthias Hartmann
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

Review 3.  Virulence of enterococci.

Authors:  B D Jett; M M Huycke; M S Gilmore
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

4.  Bacteriocin production in vancomycin-resistant and vancomycin-susceptible Enterococcus isolates of different origins.

Authors:  R del Campo; C Tenorio; R Jiménez-Díaz; C Rubio; R Gómez-Lus; F Baquero; C Torres
Journal:  Antimicrob Agents Chemother       Date:  2001-03       Impact factor: 5.191

5.  Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene.

Authors:  M A Navaratna; H G Sahl; J R Tagg
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  A novel means of self-protection, unrelated to toxin activation, confers immunity to the bactericidal effects of the Enterococcus faecalis cytolysin.

Authors:  P S Coburn; L E Hancock; M C Booth; M S Gilmore
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

7.  Intravenous mouse infection model for studying the pathology of Enterococcus faecalis infections.

Authors:  Claudia Gentry-Weeks; Monica Estay; Cindy Loui; Dale Baker
Journal:  Infect Immun       Date:  2003-03       Impact factor: 3.441

8.  Plasmid-associated hemolysin and aggregation substance production contribute to virulence in experimental enterococcal endocarditis.

Authors:  J W Chow; L A Thal; M B Perri; J A Vazquez; S M Donabedian; D B Clewell; M J Zervos
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

9.  Inhibition of vancomycin and high-level aminoglycoside-resistant enterococci strains and Listeria monocytogenes by bacteriocin-like substance produced by Enterococcus faecium E86.

Authors:  Marco Antônio Lemos Miguel; Angela Cristina Dias de Castro; Selma Ferreira Gomes Leite
Journal:  Curr Microbiol       Date:  2008-08-21       Impact factor: 2.188

10.  Substrate control in stereoselective lanthionine biosynthesis.

Authors:  Weixin Tang; Gonzalo Jiménez-Osés; K N Houk; Wilfred A van der Donk
Journal:  Nat Chem       Date:  2014-11-24       Impact factor: 24.427

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.